Lifecare ASA — AGM Information 2021

Sep 16, 2021

Notification of Extraordinary General Meeting

Notification of Extraordinary General Meeting

Bergen, Norway 16.09.21

Today the Board of Directors (the “Board”) of Lifecare AS (the “Company” or “Lifecare”) has passed a resolution to convene an Extraordinary General Meeting ("EGM") on 30 September 2021 to approve a revocation of a board authorization for a share capital increase of up to NOK 3.238.093 of the Company's share capital passed by the Company’s EGM on 30 July 2020. The resolution is part of the process towards the planned capital increase previously announced.

Notice of the EGM is enclosed to this announcement.

To save the environment and reduce costs incurred sending the notification by post to the shareholders, please see attached a manual (in Norwegian) on how to receive notices and information electronically instead of by post.

This is Lifecare

Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth Oslo (LIFE).

Further information

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Kine Hereid, Investor Relations at Lifecare AS, on 16.09.2021 at 16:30 CET.